Symposium: Inauguration Symposium for Theranostics Trial Center

Inauguration Symposium for Theranostics Trial Center – bringing together national and international experts in the field of onco-theranostics.

The upcoming symposium will bring together national and international experts in the field of onco-theranostics, including pre-clinical and translational researchers, nuclear medicine specialists, oncologists, radiologists, medical physicists and representatives of Swedish pharmaceutical companies, patient organizations and decision-makers.  Topics include advancements in targeting substances for diagnostic and therapeutic purposes, dosimetry, whole-body PET, and clinical applications. See the program below The symposium is free of charge. Register to secure your attendance and submit abstract for poster session. Register here! Target audience: Scientists, researchers, clinicians, policymakers, regulatory agents, patient representatives, students Purpose: to provide a current state-of-the-art, inspiring future glimpse of new developments in the field of radiopharmaceuticals and showcase activities within the TTC.

Preliminary program

From 8.30           Coffee, registration 9.00-9.15            Welcome Rimma Axelsson, Professor Nuclear Medicine, Founder of TTC Mathias Axelsson, Head of Medical Diagnostics Karolinska University Hospital Lars Holmgren, Professor and Head of Department of Oncology-Pathology 9.20-10.00          State-of-the-art overview of theranostics: use in clinical practice and ongoing trials Désirée Deandreis, Professor, chief of the nuclear medicine division at Gustave Roussy and University of Turin, France 10.00-10.30       Coffee and posters 10.30-11.00       Development of protein-based theranostic pairs from an industrial perspective Fredrik Frejd, Professor Uppsala University and CSO Affibody AB Sweden. 11.00-11.15       Theranostic trials in pediatric oncology Jakob Stenman, Associate professor Karolinska Institutet and Pediatric surgeon at Karolinska University Hospital, Stockholm, Sweden 11.15 -11.30      Starting early-stage clinical trials with radiopharmaceuticals Renske Altena,  Associate professor, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden 11.30-12.30       Lunch and posters 12.30-13.00       Physicist perspective – dosimetry of new radiotheranostic products Caroline Stokke, Professor and Head of Nuclear Medicine & PET Physics, Oslo University Hospital, Norway 13.00- 13.30      At-221 and beyond Stig Palm, Associate professor, Department of Radiation Physics, Sahlgrenska Academy at the    University of Gothenburg, Gothenburg, Sweden 13.30-14.00          Advances and future perspectives of 161-Tb-labelled radiopharmaceuticals. Christina Müller, Professor Paul Scherrer Institute, Center for Radiopharmaceutical Sciences, Switzerland  14.00-14.30       Coffee and poster 14.30-15.15       New possibilities with whole body PET-cameras Adrienne H Brouwers, Professor Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, The Netherlands 15.15-16.00       Panel Discussion 16.00-16.15       Concluding Remarks and Poster Prize The organization committee consists of Rimma Axelsson, Cecilia Hindorf, Antonios Tzortzakakis and Thuy Tran. Welcome!